< Back to previous page
Researcher
Steven De Vleeschouwer
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Responsible
From1 Jan 2013 → Today - Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2001 → Today
Projects
1 - 10 of 32
- Circuit control by Astrocytes Located in Microenvironment of GlioblastomaFrom15 Jan 2026 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- CALM-GBM: Circuit control by Astrocytes Located in Microenvironment of GlioblastomaFrom1 Oct 2025 → TodayFunding: FWO junior postdoctoral fellowship
- AIM-GBM: Astrocyte involvement in glioblastoma microenvironment, invasion, and growthFrom23 Jul 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- NOSE2BRAIN: Towards the first transnasal delivery of RNAi technology into the (tumor) microenvironment of the human brainFrom21 Jul 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- NOSE2BRAIN : Towards first-in-human transnasal delivery of RNAi technology to the brain (tumor) micro-environmentFrom1 Mar 2025 → TodayFunding: IOF - technology validation in lab
- Hyperthermia with Advanced Targeted Therapy in Glioblastoma (HeATTinG)From1 Jan 2025 → TodayFunding: FWO research project (including WEAVE projects)
- Activating novel immunogenic metaprograms in cancer cells to facilitate anti-glioblastoma immunotherapy (iGLIO)From1 Oct 2024 → TodayFunding: BOF - projects
- GlioSELECT: A multi-omic single-cell, functional precision oncology platform to guide personalized medicine in high-grade brain tumorsFrom1 Oct 2024 → TodayFunding: FWO Strategic Basic Research (SBO)
- The malignant Glioma immuno-oncology matchmaker: towardsdata-driven precision medicine using spatially resolved radio-multiomicsFrom1 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular Brain Tumor DetectorFrom1 Feb 2024 → TodayFunding: Other EU initiatives out of framework
Publications
131 - 138 of 138
- Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination(2010)Published in: Journal of Immunological MethodsISSN: 0022-1759Issue: 1Volume: 352Pages: 169 - 173
- Abstracts from the 2009 Joint Meeting of the Society for Neuro-Oncology (SNO) and the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) Section on Tumors: October 22–24, 2009: New Orleans, LA(2009)Published in: NEURO-ONCOLOGYISSN: 1522-8517Issue: 5Volume: 11Pages: 564 - 699
- Dendritic Cell Therapy of High-Grade Gliomas(2009)Published in: BRAIN PATHOLOGYISSN: 1015-6305Issue: 4Volume: 19Pages: 694 - 712
- DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma(2009)Published in: NEURO-ONCOLOGYISSN: 1522-8517Issue: 5Volume: 11Pages: 529 - 542
- Malignant glioma or brain abscess? A diagnostic pitfall in 2 cases(2009)Published in: Surgical NeurologyISSN: 0090-3019Issue: 1Volume: 71Pages: 144 - 144
- Neuro imaging; Uw diagnose? Bij de neus genomen(2009)Published in: Tijdschrift voor Neurologie en NeurochirurgieISSN: 1571-5930Issue: 4Volume: 2Pages: 200 - 201
- Immunotherapie voor hooggradige gliomen: alive and kicking?(2008)Published in: ONCOIssue: 6Volume: 2Pages: 232 - 240
- Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme(2008)Published in: CLINICAL CANCER RESEARCHISSN: 1078-0432Issue: 10Volume: 14Pages: 3098 - 3104